ChemImpex 4-Hydroxytamoxifen; >= 99% (HPLC); 68047-06-3; MFCD00278780, 25MG

4-Hydroxytamoxifen is a potent selective estrogen receptor modulator (SERM) widely recognized for its role in breast cancer treatment and research. This compound is a key metabolite of Tamoxifen, enhancing its efficacy in targeting estrogen receptors, particularly in hormone receptor-positive breast cancer. Researchers and healthcare professionals utilize 4-Hydroxytamoxifen not only for its therapeutic applications but also for its potential in studying estrogen-related pathways and mechanisms of resistance in cancer therapies. Its unique structure allows for effective binding to estrogen receptors, making it a valuable tool in both clinical and laboratory settings.

In addition to its primary use in oncology, 4-Hydroxytamoxifen has been explored in various research contexts, including reproductive health and endocrine system studies. Its ability to modulate estrogen activity makes it a significant compound for investigating hormonal influences on various biological processes. With its established safety profile and effectiveness, 4-Hydroxytamoxifen continues to be a critical asset for researchers and clinicians aiming to improve treatment outcomes and understand complex hormonal interactions.

Specifications

Safety & Regulations